Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma

Journal of Investigative Dermatology

Volumn 132, Issue 4, 2012, Pages 1247-1252

  Ladstein, Rita G ^a   Bachmann, Ingeborg M ^a,b   Straume, Oddbjørn ^a   Akslen, Lars A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; HISTONE H3; PHOSPHOHISTONE H3; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SKIN NODULE; SKIN ULCER; TUMOR VOLUME;

EID: 84858296891     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.464     Document Type: Article

References (21)

1. Angi M, Damato B, Kalirai H et al. (2011) Immunohistochemical assessment of mitotic count in uveal melanoma. Acta Ophthalmol 89:e155-60
2. Attis MG, Vollmer RT (2007) Mitotic rate in melanoma: A reexamination. Am J Clin Pathol 127:380-4
3. Balch CM, Gershenwald JE, Atkins MB (2009a) Melanoma of the skin. In: AJCC Cancer Staging Manual (Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds) 7th ed, New York: Springer, 325-44
4. Balch CM, Gershenwald JE, Soong SJ et al. (2009b) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199-205
5. Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-8
6. Casper DJ, Ross KI, Messina JL et al. (2010) Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma. Am J Dermatopathol 32:650-4
7. Clark WH Jr, From L, Bernardino EA et al. (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705-27
8. Glatz K, Hartmann C, Antic M et al. (2010) Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis. Am J Dermatopathol 32:643-9
9. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144:646-74
10. Hendzel MJ, Nishioka WK, Raymond Y et al. (1998) Chromatin condensation is not associated with apoptosis. J Biol Chem 273:24470-8
11. Hendzel MJ,Wei Y, Mancini MA et al. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106:348-60
12. Juan G, Traganos F, James WM et al. (1998) Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 32:71-7
13. Ladstein RG, Bachmann IM, Straume O et al. (2010) Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. BMC Cancer 10:140
14. Nasr MR, El-Zammar O (2008) Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 30:117-22
15. Scolyer RA, Mihm MC Jr, Cochran AJ et al. (2009) Pathology of melanoma. In: Cutaneous Melanoma (Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, eds) 5th ed, St Louis, Missouri: Quality Medical Publishing, Inc., 205-47
16. Scolyer RA, Shaw HM, Thompson JF et al. (2003) Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol 27:1571-5
17. Skaland I, Janssen EA, Gudlaugsson E et al. (2007) Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age. Mod Pathol 20:1307-15
18. Straume O, Akslen LA (2001) Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. Am J Pathol 159:223-35
19. Straume O, Sviland L, Akslen LA (2000) Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Clin Cancer Res 6:1845-53
20. Tapia C, Kutzner H, Mentzel T et al. (2006) Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol 30:83-9
21. Thompson JF, Soong SJ, Balch CM et al. (2011) Prognostic significance of mitotic rate in localized primary cutaneous melanoma: An analysis of patients in the multi-institutional american joint committee on cancer melanoma staging database. J Clin Oncol 29:2199-205